Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Accounts Payables (2018 - 2025)

Historic Accounts Payables for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $20.4 million.

  • Dna X's Accounts Payables rose 12535.34% to $20.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year increase of 12535.34%. This contributed to the annual value of $22.8 million for FY2024, which is 1512.07% up from last year.
  • As of Q3 2025, Dna X's Accounts Payables stood at $20.4 million, which was up 12535.34% from $20.6 million recorded in Q2 2025.
  • In the past 5 years, Dna X's Accounts Payables registered a high of $23.3 million during Q3 2023, and its lowest value of $8.1 million during Q2 2022.
  • Moreover, its 5-year median value for Accounts Payables was $16.3 million (2021), whereas its average is $15.7 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 15723.25% in 2023, then crashed by 6105.95% in 2024.
  • Dna X's Accounts Payables (Quarter) stood at $9.5 million in 2021, then surged by 123.01% to $21.1 million in 2022, then fell by 6.05% to $19.8 million in 2023, then grew by 15.12% to $22.8 million in 2024, then dropped by 10.68% to $20.4 million in 2025.
  • Its Accounts Payables was $20.4 million in Q3 2025, compared to $20.6 million in Q2 2025 and $17.3 million in Q1 2025.